Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polyps

Diagnostic Pathology

Klaus J Schmitz²  Kurt W Schmid¹  Hideo A Baba¹  Nimet Dayi³ 

[1] Institute of Pathology and Neuropathology, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany;Institute of Pathology Recklinghausen, Mühlenstrasse 31, 45659 Recklinghausen, Germany;St. Barbara-Hospital, Barbarastrasse 1, 45964 Gladbeck, Germany

关键词: Sessile serrated adenoma;    Hyperplastic polyp;    p16^Ink4a;    AMACR;   

Others  :  804105
DOI  :  10.1186/1746-1596-8-178

 received in 2013-09-09, accepted in 2013-10-15,  发布年份 2013

【 摘 要 】

Background

Hyperplastic polyps (HP) and sessile serrated adenomas (SSA) share morphological similarities. In this immunohistochemical study we chose a panel of potential relevant and promising biomarkers including α-methylacyl-coenzyme A racemase (AMACR; p504s), which is involved in the degradation of branched chained fatty acids derivates, and analysed a cohort of HPs and SSAs in order to identify different immunophenotypes in relation to lesion localisation.

Methods

154 specimen were carefully selected and a micro tissue array (TMA) was constructed. Immunohistochemistry of p16^Ink4a, Ki67, α-methylacyl-coenzyme A racemase (AMACR; p504s), BRAF, CK 20, MLH1 and β-catenin was performed and and immunoexpression was compared among proximal and distal HPs as well as SSAs.

Results

None of the markers revealed a differential expression among HPs and SSAs. However, the study demonstrates a significant overexpression of AMACR (p = 0.004) and p16^Ink4a (p = 0.028) in distal HPs compared to proximal HPs. In addition AMACR overexpression was associated with increased p16^Ink4a immunoexpression (p < 0.001).

Conclusions

In this study we describe differential AMACR and p16^Ink4a in HPs in relation to their localisation. Distal HPs were characterized by AMACR and p16^Ink4a overexpression in contrast to proximal HPs, although morphological identically. Thus AMACR overexpression points towards a pathobiological relevance of the protein in distal HPs. In context of recently published data this suggest distal HPs as potential precursor lesions of certain adenoma subtypes. However, at this point of time this finding remains speculative and needs to be confirmed by further studies.

Virtual slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1836116001066768 webcite

【 授权许可】

   
2013 Dayi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Morson BC: Precancerous lesions of the colon and rectum. Classification and controversial issues. JAMA 1962, 179:316-321.
• [2]Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
• [3]Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003, 27:65-81.
• [4]Torlakovic E, Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 1996, 110:748-755.
• [5]Jass JR, Smith M: Sialic acid and epithelial differentiation in colorectal polyps and cancer–a morphological, mucin and lectin histochemical study. Pathology 1992, 24:233-242.
• [6]Yao T, Nishiyama KI, Oya M, Kouzuki T, Kajiwara M, Tsuneyoshi M: Multiple “serrated adenocarcinomas” of the colon with a cell lineage common to metaplastic polyp and serrated adenoma. Case report of a new subtype of colonic adenocarcinoma with gastric differentiation. J Pathol 2000, 190:444-449.
• [7]Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004, 53:1137-1144.
• [8]Tateyama H, Li W, Takahashi E, Miura Y, Sugiura H, Eimoto T: Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol 2002, 26:249-256.
• [9]Jass JR, Whitehall VLJ, Young J, Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 2002, 123:862-876.
• [10]Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999, 96:8681-8686.
• [11]Baretton GB, Autschbach F, Baldus S, Blaker H, Faller G, Koch HK, Langner C, Luttges J, Neid M, Schirmacher P, Tannapfel A, Vieth M, Aust DE: [Histopathological diagnosis and differential diagnosis of colorectal serrated polys: findings of a consensus conference of the working group “gastroenterological pathology of the german society of pathology”]. Pathologe 2011, 32:76-82.
• [12]Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL: Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009, 62:516-518.
• [13]Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VLJ, Pike T, Simms LA, Young J, James M, Montgomery GW, Appleyard M, Hewett D, Togashi K, Jass JR, Leggett BA: High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006, 131:1400-1407.
• [14]Kriegl L, Neumann J, Vieth M, Greten FR, Reu S, Jung A, Kirchner T: Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod Pathol 2011, 24:1015-1022.
• [15]Ferdinandusse S, Denis S, IJlst L, Dacremont G, Waterham HR, RJ W: Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 2000, 41:1890-1896.
• [16]Marx A, Simon P, Simon R, Mirlacher M, Izbicki JR, Yekebas E, Kaifi JT, Terracciano L, Sauter G: AMACR expression in colorectal cancer is associated with left-sided tumor localization. Virchows Arch 2008, 453:243-248.
• [17]Zhang X, Leav I, Revelo MP, Deka R, Medvedovic M, Jiang Z, Ho S-M: Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon. PLoS Genet 2009, 5:e1000334.
• [18]Lakis S, Papamitsou T, Panagiotopoulou C, Kotakidou R, Kotoula V: AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas. World J Gastroenterol 2010, 16:2476-2483.
• [19]Schmitz KJ, Lang H, Wohlschlaeger J, Reis H, Sotiropoulos GC, Schmid KW, Baba HA: Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma. Virchows Arch 2007, 450:135-141.
• [20]Jiang Z, Li C, Fischer A, Dresser K, Woda BA: Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol 2005, 123:231-236.
• [21]Snover DC: Serrated polyps of the large intestine. Semin Diagn Pathol 2005, 22:301-308.
• [22]Dorer R, Odze RD: AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett“s esophagus, ulcerative colitis, and Crohn”s disease. Am J Surg Pathol 2006, 30:871-877.
• [23]Fujimori Y, Fujimori T, Imura J, Sugai T, Yao T, Wada R, Ajioka Y, Ohkura Y: An assessment of the diagnostic criteria for sessile serrated adenoma/polyps: SSA/Ps using image processing software analysis for Ki67 immunohistochemistry. Diagn Pathol 2012, 7:59.
• [24]Collado M, Blasco MA, Serrano M: Cellular senescence in cancer and aging. Cell 2007, 130:223-233.
• [25]Campisi J, d’Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007, 8:729-740.